FMSDX
Price
$13.83
Change
+$0.06 (+0.44%)
Updated
May 8 closing price
Net Assets
2.74B
RLBAX
Price
$34.02
Change
+$0.04 (+0.12%)
Updated
May 8 closing price
Net Assets
234.05B
Ad is loading...

FMSDX vs RLBAX

Header iconFMSDX vs RLBAX Comparison
Open Charts FMSDX vs RLBAXBanner chart's image
Fidelity Multi-Asset Income
Price$13.83
Change+$0.06 (+0.44%)
VolumeN/A
Net Assets2.74B
American Funds American Balanced R1
Price$34.02
Change+$0.04 (+0.12%)
VolumeN/A
Net Assets234.05B
FMSDX vs RLBAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FMSDX vs. RLBAX commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FMSDX is a Buy and RLBAX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RLBAX has more cash in the bank: 234B vs. FMSDX (2.74B). FMSDX pays higher dividends than RLBAX: FMSDX (3.97) vs RLBAX (1.28). FMSDX was incepted earlier than RLBAX: FMSDX (7 years) vs RLBAX (23 years). RLBAX (1.31) is less costly to investors than FMSDX (0.80). FMSDX is a more actively managed with annual turnover of: 230.00 vs. RLBAX (44.00). FMSDX has a lower initial minimum investment than RLBAX: FMSDX (0) vs RLBAX (250). FMSDX annual gain was more profitable for investors over the last year : 4.32 vs. RLBAX (3.92). FMSDX return over 5 years is better than : 50.77 vs. RLBAX (32.45).
FMSDXRLBAXFMSDX / RLBAX
Total Expense Ratio0.801.3161%
Annual Report Gross Expense Ratio0.801.3161%
Fund Existence7 years23 years-
Gain YTD-1.3590.154-880%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets2.74B234B1%
Annual Yield % from dividends3.971.28311%
Returns for 1 year4.323.92110%
Returns for 3 years20.2519.69103%
Returns for 5 years50.7732.45156%
Returns for 10 yearsN/A44.47-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MIEGX10.63N/A
N/A
BNY Mellon Emerging Markets Inv
LGOPX22.77N/A
N/A
Lord Abbett Growth Opportunities P
SAMVX11.16N/A
N/A
Virtus Ceredex Mid-Cap Value Equity A
GMNCX10.18N/A
N/A
Gabelli Global Mini Mites C
VSRAX21.12N/A
N/A
Invesco Small Cap Value R